<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Immunology</journal-id>
<journal-id journal-id-type="iso-abbrev">Immunology</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1365-2567</journal-id>
<journal-id journal-id-type="publisher-id">IMM</journal-id>
<journal-title-group>
<journal-title>Immunology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0019-2805</issn>
<issn pub-type="epub">1365-2567</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29513402</article-id>
<article-id pub-id-type="pmc">5980185</article-id>
<article-id pub-id-type="doi">10.1111/imm.12922</article-id>
<article-id pub-id-type="publisher-id">IMM12922</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Review Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Inflammation in CNS neurodegenerative diseases</article-title>
<alt-title alt-title-type="left-running-head">J. Stephenson <italic>et al</italic>.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="imm12922-cr-0001">
<name>
<surname>Stephenson</surname>
<given-names>Jodie</given-names>
</name>
<xref ref-type="aff" rid="imm12922-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="imm12922-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="imm12922-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="imm12922-cr-0002">
<name>
<surname>Nutma</surname>
<given-names>Erik</given-names>
</name>
<xref ref-type="aff" rid="imm12922-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="imm12922-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="imm12922-cr-0003">
<name>
<surname>van der Valk</surname>
<given-names>Paul</given-names>
</name>
<xref ref-type="aff" rid="imm12922-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="imm12922-cr-0004">
<name>
<surname>Amor</surname>
<given-names>Sandra</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6169-9845</contrib-id>
<address>
<email>s.amor@vumc.nl</email>
</address>
<xref ref-type="aff" rid="imm12922-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="imm12922-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="imm12922-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Centre for Neuroscience and Trauma</named-content>
<institution>Barts and the Blizard Institute, London</institution>
<institution>School of Medicine and Dentistry</institution>
<institution>Queen Mary University of London</institution>
<named-content content-type="city">London</named-content>
<country country="GB">UK</country>
</aff>
<aff id="imm12922-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Pathology</named-content>
<institution>VU University Medical Centre</institution>
<named-content content-type="city">Amsterdam</named-content>
<country country="NL">the Netherlands</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>
Correspondence: Professor Sandra Amor, Department of Pathology, VU Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. Email: <email>s.amor@vumc.nl</email><break></break>
Senior author: Sandra Amor<break></break></corresp>
<fn id="imm12922-note-1001">
<label>†</label>
<p>J.S. and E.N. are joint first authors.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<volume>154</volume>
<issue>2</issue>
<issue-id pub-id-type="doi">10.1111/imm.2018.154.issue-2</issue-id>
<fpage>204</fpage>
<lpage>219</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>22</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2018 John Wiley & Sons Ltd <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 John Wiley &amp; Sons Ltd</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:IMM-154-204.pdf" xlink:type="simple"></self-uri>
<abstract id="imm12922-abs-0001">
<title>Summary</title>
<p>Neurodegenerative diseases, the leading cause of morbidity and disability, are gaining increased attention as they impose a considerable socioeconomic impact, due in part to the ageing community. Neuronal damage is a pathological hallmark of Alzheimer's and Parkinson's diseases, amyotrophic lateral sclerosis, Huntington's disease, spinocerebellar ataxia and multiple sclerosis, although such damage is also observed following neurotropic viral infections, stroke, genetic white matter diseases and paraneoplastic disorders. Despite the different aetiologies, for example, infections, genetic mutations, trauma and protein aggregations, neuronal damage is frequently associated with chronic activation of an innate immune response in the <styled-content style="fixed-case">CNS</styled-content>. The growing awareness that the immune system is inextricably involved in shaping the brain during development as well as mediating damage, but also regeneration and repair, has stimulated therapeutic approaches to modulate the immune system in neurodegenerative diseases. Here, we review the current understanding of how astrocytes and microglia, as well as neurons and oligodendrocytes, shape the neuroimmune response during development, and how aberrant responses that arise due to genetic or environmental triggers may predispose the <styled-content style="fixed-case">CNS</styled-content> to neurodegenerative diseases. We discuss the known interactions between the peripheral immune system and the brain, and review the current concepts on how immune cells enter and leave the <styled-content style="fixed-case">CNS</styled-content>. A better understanding of neuroimmune interactions during development and disease will be key to further manipulating these responses and the development of effective therapies to improve quality of life, and reduce the impact of neuroinflammatory and degenerative diseases.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="imm12922-kwd-0001">immune response</kwd>
<kwd id="imm12922-kwd-0002">inflammation</kwd>
<kwd id="imm12922-kwd-0003">microbiome</kwd>
<kwd id="imm12922-kwd-0004">neuroprotection</kwd>
<kwd id="imm12922-kwd-0005">repair</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Multiple Sclerosis Society</funding-source>
</award-group>
<award-group>
<funding-source>Stichting MS Research</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="4"></table-count>
<page-count count="16"></page-count>
<word-count count="11897"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>imm12922</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.0 mode:remove_FC converted:31.05.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>